Literature DB >> 11216880

Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood.

T Kanai1, T Fujii, N Unno, T Yamashita, H Hyodo, A Miki, Y Hamai, S Kozuma, Y Taketani.   

Abstract

PROBLEM: To better understand the role of human leukocyte antigen (HLA)-G in regulating the T helper (Th)1/Th2 cytokine balance, one of key conditions in determining the fate of pregnancy, we asked whether the presence of HLA-G protein altered the release of cytokines from both decidual mononuclear cells and peripheral blood mononuclear cells (PBMCs). METHOD OF STUDY: The amounts of cytokines released from decidual mononuclear cells and PBMCs were compared in the presence or absence of HLA-G-expressing cells.
RESULTS: When cocultured with HLA-G-expressing cells, the amounts of tumor necrosis factor-alpha and interferon-gamma released from decidual mononuclear cells and PBMCs were decreased, while the amounts of interleukin (IL)-4 from PBMCs was increased, with IL-4 release from decidual mononuclear cells being unchanged.
CONCLUSIONS: Upon contact with HLA-G, decidual mononuclear cells, and PBMCs as well, modulate their ability to release cytokines in a way that may shift the Th1/Th2 balance towards relative Th2 dominance, suggesting a role for HLA-G in maintaining pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216880     DOI: 10.1111/j.8755-8920.2001.450205.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  26 in total

1.  Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism.

Authors:  N Lila; N Rouas-Freiss; J Dausset; A Carpentier; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 2.  Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy.

Authors:  Irene Athanassakis; S Vassiliadis
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

Review 3.  Nanoparticles targeting HLA-G for gene therapy in cancer.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

4.  The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cells.

Authors:  Breno Luiz Melo-Lima; Isabelle Poras; Geraldo Aleixo Passos; Edgardo D Carosella; Eduardo Antonio Donadi; Philippe Moreau
Journal:  Immunology       Date:  2019-08-19       Impact factor: 7.397

5.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

Review 6.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

7.  Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.

Authors:  M Urosevic; M O Kurrer; J Kamarashev; B Mueller; W Weder; G Burg; R A Stahel; R Dummer; A Trojan
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

8.  Soluble HLA-G induces NF-kappaB activation in natural killer cells.

Authors:  I Zidi; C Guillard; E D Carosella; P Moreau
Journal:  J Physiol Biochem       Date:  2010-04-20       Impact factor: 4.158

9.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

10.  HLA-G does not have a pathophysiological role in Graves' disease.

Authors:  E H Kemp; R A Metcalfe; P F Watson; A P Weetman
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.